Phenyl-thiophene type vitamin D receptor modulators
申请人:Eli Lilly & Company
公开号:EP2184281A1
公开(公告)日:2010-05-12
The present invention relates to novel, non-secosteroidal, phenyl-thiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
本发明涉及具有维生素 D 受体(VDR)调节活性的新型非甾体苯基噻吩化合物,其高钙血症性低于 1α,25 二羟基维生素 D3。这些化合物可用于治疗骨病和牛皮癣。
Vandenbroucke,W.; Anteunis,M., Journal of the Chemical Society. Perkin transactions II, 1972, p. 123 - 127
作者:Vandenbroucke,W.、Anteunis,M.
DOI:——
日期:——
DUCHENE, A.;MOUKO-MPEGNA, D.;QUINTARD, J. -P., BULL. SOC. CHIM. FR., 1985, N 5, 787-793
作者:DUCHENE, A.、MOUKO-MPEGNA, D.、QUINTARD, J. -P.
DOI:——
日期:——
Duchene, Alain; Mouko-Mpegna, David; Quintard, Jean-Paul, Bulletin de la Societe Chimique de France, 1985, # 5, p. 787 - 793